Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 22.89%220.53M | ---- | ---- | ---- | -27.62%179.46M | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | 12.46%-26.37M | ---- | ---- | ---- | -78.23%-30.12M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 167.80%58.21M | ---- | ---- | ---- | -15.27%21.74M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -118.52%-5.26M | ---- | ---- | ---- | 43.32%28.41M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | -191.31%-6.47M | ---- | ---- | ---- | -4,527.08%-2.22M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | -96.05%1.21M | ---- | ---- | ---- | 54.15%30.63M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -28.51%18.15M | ---- | ---- | ---- | 6,004.33%25.39M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -28.51%18.15M | ---- | ---- | ---- | 6,004.33%25.39M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -135.41%-16.68M | ---- | ---- | ---- | -540.69%-7.09M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -134.25%-6.4M | ---- | ---- | ---- | -147.11%-2.73M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | -136.14%-10.28M | ---- | ---- | ---- | ---4.35M | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | 14.73%252.74M | ---- | ---- | ---- | -5.21%220.3M | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | -7.31%33.07M | ---- | ---- | ---- | -9.57%35.67M | ---- | ---- |
| Financial expense | ---- | ---- | ---- | 17.38%74.38M | ---- | ---- | ---- | 107.28%63.37M | ---- | ---- |
| Special items | ---- | ---- | ---- | -9,737.44%-83.65M | ---- | ---- | ---- | -77.91%868K | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | -2.04%492.06M | ---- | ---- | ---- | -7.45%502.32M | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -108.32%-18.04M | ---- | ---- | ---- | 956.39%216.89M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -62.70%-105.7M | ---- | ---- | ---- | -117.40%-64.97M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | -2,152.54%-12.86M | ---- | ---- | ---- | 99.81%-571K | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 44.38%-2.71M | ---- | ---- | ---- | -225.70%-4.88M | ---- | ---- |
| Cash from business operations | ---- | 820.87%201.8M | ---- | -45.63%352.74M | ---- | -91.61%21.91M | ---- | 2.06%648.79M | ---- | -4.76%261.19M |
| Other taxs | ---- | -31.99%-83.99M | ---- | -32.81%-99.83M | ---- | -8.87%-63.64M | ---- | 5.18%-75.17M | ---- | 14.58%-58.45M |
| Net cash from operations | -28.12%119.78M | 382.36%117.81M | 425.81%130.21M | -55.91%252.92M | -23.34%166.64M | -120.58%-41.72M | -3.30%24.76M | 3.09%573.63M | -36.32%217.37M | -1.50%202.74M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 10.45%16.11M | ---- | -13.22%26.14M | ---- | -2.16%14.59M | ---- | 78.23%30.12M | ---- | 125.73%14.91M |
| Decrease in deposits (increase) | ---- | 16.92%-115.2M | ---- | -161.18%-37.86M | ---- | -455.75%-138.66M | ---- | 92.30%61.89M | ---- | 608.24%38.98M |
| Sale of fixed assets | ---- | 30.69%18.44M | ---- | -45.73%13.3M | ---- | 3.76%14.11M | ---- | 181.78%24.51M | ---- | 105.01%13.6M |
| Purchase of fixed assets | ---- | -34.16%-281.48M | ---- | -39.84%-374.51M | ---- | -124.25%-209.81M | ---- | -119.95%-267.81M | ---- | -83.30%-93.56M |
| Selling intangible assets | ---- | ---- | ---- | 97.55%7.03M | ---- | ---- | ---- | --3.56M | ---- | ---- |
| Purchase of intangible assets | ---- | -102.52%-2.25M | ---- | 73.76%-11.22M | ---- | -4.12%-1.11M | ---- | -341.71%-42.77M | ---- | 66.38%-1.07M |
| Sale of subsidiaries | ---- | --3.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | 47.11%21.16M | ---- | 89.90%14.82M | ---- | -12.80%14.39M | ---- | -0.83%7.8M |
| Cash on investment | ---- | 116.81%8.45M | ---- | 77.35%-7.95M | ---- | 112.73%3.9M | ---- | -2,023.35%-35.1M | ---- | -2,779.96%-30.61M |
| Other items in the investment business | ---- | ---- | ---- | 44.37%-110.7M | ---- | ---- | ---- | ---199M | ---- | ---- |
| Net cash from investment operations | 8.84%-406.07M | -16.51%-352.06M | -37.42%-270.28M | -15.70%-474.61M | -13.55%-445.44M | -504.84%-302.17M | -1,266.26%-196.68M | -519.99%-410.21M | -295.23%-392.27M | -1.55%-49.96M |
| Net cash before financing | ---- | 31.88%-234.25M | ---- | -235.67%-221.7M | ---- | -325.08%-343.89M | ---- | -66.67%163.41M | ---- | -2.46%152.78M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 12.44%4.15B | ---- | 389.29%6.7B | ---- | 431.13%3.69B | ---- | 22.99%1.37B | ---- | -21.94%694.44M |
| Refund | ---- | -10.23%-3.91B | ---- | -528.54%-6.54B | ---- | -1,038.27%-3.55B | ---- | 22.23%-1.04B | ---- | 65.21%-311.59M |
| Issuing shares | ---- | --2.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 5.06%-38M | ---- | -28.90%-81.68M | ---- | -50.53%-40.02M | ---- | -107.28%-63.37M | ---- | -205.68%-26.59M |
| Absorb investment income | ---- | ---- | ---- | -1.89%416K | ---- | ---- | ---- | --424K | ---- | ---- |
| Other items of the financing business | ---- | ---2.48M | ---- | 28.93%-688K | ---- | ---- | ---- | 50.66%-968K | ---- | ---968K |
| Net cash from financing operations | 24.01%143.51M | 96.12%191.52M | 16.81%302.71M | -76.34%58.82M | -72.76%115.73M | -72.20%97.65M | 1,722.00%259.14M | 191.99%248.58M | 938.61%424.82M | 1,479.12%351.29M |
| Effect of rate | 178.93%24.78M | 168.46%30.45M | 220.00%30.06M | -320.37%-40.69M | 47.36%-31.39M | -28.68%-44.47M | -328.66%-25.05M | 87.17%-9.68M | 48.24%-59.64M | 25.98%-34.56M |
| Net Cash | 39.32%-118.01M | 82.65%-42.73M | 209.88%192.69M | -139.53%-162.88M | -202.20%-194.47M | -148.85%-246.24M | -8.08%62.18M | 87.23%412M | 149.67%190.28M | 284.32%504.07M |
| Begining period cash | -15.46%1.11B | -15.46%1.11B | -15.46%1.11B | 44.02%1.32B | 44.02%1.32B | 44.02%1.32B | 44.02%1.32B | 18.79%914.05M | 18.79%914.05M | 18.79%914.05M |
| Cash at the end | -11.33%994.79M | 7.30%1.1B | -5.30%1.31B | -15.46%1.11B | 1.59%1.12B | -25.87%1.03B | 40.43%1.38B | 44.02%1.32B | 30.59%1.1B | 62.02%1.38B |
| Cash balance analysis | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.